Exploring the current advancements of quercetin nanoformulations alleviating respiratory diseases

Future Med Chem. 2024;16(10):925-928. doi: 10.1080/17568919.2024.2347067. Epub 2024 May 10.

Authors

Stewart Yeung^{1

2}, Keshav Raj Paudel³, Gabriele De Rubis^{1

2}, Kylie A Williams¹, Philip Michael Hansbro³, Kamal Dua^{1

2}

Affiliations

¹ Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, 2007, Australia.
² Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, Australia.
³ Centre for Inflammation, Centenary Institute & University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia.

PMID: 38910578
PMCID: PMC11216629 (available on 2025-05-10)
DOI: 10.1080/17568919.2024.2347067

No abstract available

Keywords: nanoformulations; nanoparticles; quercetin; respiratory diseases.

Publication types

Editorial

MeSH terms

Antioxidants / chemistry
Antioxidants / pharmacology
Humans
Nanoparticles* / chemistry
Quercetin* / chemistry
Quercetin* / pharmacology
Quercetin* / therapeutic use
Respiratory Tract Diseases / drug therapy

Substances

Quercetin
Antioxidants

Grants and funding